Science Central - All about Science

Wednesday, 22 May, 2013

search

for
Directories
 
 
 
 Recent Listings
  Plant, Animal and Environmental Sciences [IJPAES]
  Public Health and Medical Research
  The Indian Journal Of Pharmacy Research (IJPOR)
  Bradford Private Investigator
  Basic Medical Sciences and Pharmacy (IJBMSP)
  IJAP Journal
  Applied Biology and Pharmaceutical Technology [IJABPT]
  Advanced Research In Electronics and Communication Engineering (IJARECE)
  The Journal Of Pharmacy
  The Private Detective
 
Category:  Science » Employment » Job Search UPDATE URL | REPORT BROKEN LINK

KRAS and BRAF Mutations Analysis

Popularity:    Hit: 184 | Visit: 4
Details
In the US alone, there are over 150,000 newly diagnosed cases each year. Many of these patients are diagnosed with metastatic colorectal cancer (mCRC). Although the number of patients surviving 5-years with advance stage mCRC remains small, recent advances may be better able to separate out those that respond to novel cytotoxic and biologic agents versus those that don’t respond to these agents.

Sponsored Links:


URL: http://www.clarientinc.com/clarient-home/kras-braf.aspx
Title: The BRAF (V600E) mutation analysis
Image:
Description:

The BRAF (V600E) mutation analysis is predictive for anti-EGFR therapies (i.e., cetuximab and panitumumab). BRAF mutations account for approximately 12-15% of colorectal cancer patients.

Category: Colorectal Cancer - Kras - Braf Mutations - Advance Stage Mcrc Remains Small - Novel Cytotoxic - Biologic Agents Versus


Related sites

© 2005-2010 Science Central. All Rights Reserved